Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Topic
Download App
简
繁
简
繁
EN
Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Topic
HOME
·
15th Five-Year Plan
Implementation of the Pharmaceutical Industry Development “15th Five-Year Plan” and Standout Data for Domestic Novel Drugs at WCLC: Chinaamc Hang Seng Hong Kong Biotech Index ETF (03069.HK) Rose 10.82%
Tags：
Hang Seng Biotechnology Technology ETF
WuXi AppTec
GENSCRIPT BIO
15th Five-Year Plan
2026-09-21
Finance
RIBOLIFE (06938.HK): EU filing for Phase I trial of SR122
Finance
WUXI APPTEC (02359.HK): removed from DoD 1260H CMC list
Finance
BITFIRE GROUP (01611.HK): end-October digital asset AUM HKD 1.77bn
Finance
FANTASIA (01777.HK): 3 onshore bond restructuring plans approved
Finance
DIDA INC (02559.HK): three-year travel framework with Tongcheng Travel
Finance
JF SMARTINVEST (09636.HK): 400,000 RSUs to connected person
Finance
MAJESTIC DRAGON (00918.HK): two-year drone supply framework
Research
HK Stock Connect Daily Report: MICOT PHARMA-B Rises 29.82% on Completion of Phase III Trial for MT1013 - 20261109
Finance
CITIC (00267.HK): Nangang merger still pending deregistration
Research
Hong Kong AI Concept Stock Daily: UBTECH ROBOTICS Rises 8.99% on Strategic Pact with Tianyi Telecom Terminal - 20261109
Scan QR Code
Download App
